about
Hyphenation of capillary high-performance liquid chromatography with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for nano-scale screening of single-bead combinatorial libraries.Quantitative analysis of small pharmaceutical drugs using a high repetition rate laser matrix-assisted laser/desorption ionization source.Increasing sensitivity and decreasing spot size using an inexpensive, removable hydrophobic coating for matrix-assisted laser desorption/ionisation plates.Some fundamental and technical aspects of the quantitative analysis of pharmaceutical drugs by matrix-assisted laser desorption/ionization mass spectrometry.Assessing the properties of internal standards for quantitative matrix-assisted laser desorption/ionization mass spectrometry of small molecules.Infrared multiphoton dissociation of the siderophore enterobactin and its Fe(III) complex. Influence of Fe(III) binding on dissociation kinetics and relative energetics.Quantitative analysis of antiretroviral drugs in lysates of peripheral blood mononuclear cells using MALDI-triple quadrupole mass spectrometry.Studies on azaspiracid biotoxins. I. Ultrafast high-resolution liquid chromatography/mass spectrometry separations using monolithic columns.Mass spectrometric analysis of nitrogen- and phosphorus-containing pesticides by liquid chromatography-Mass Spectrometry.The role of physical and chemical properties of Pd nanostructured materials immobilized on inorganic carriers on ion formation in atmospheric pressure laser desorption/ionization mass spectrometry.Comparative high-speed profiling of carboxylic acid metabolite levels by differential isotope-coded MALDI mass spectrometry.Isoprenoid quantitation in human brain tissue: a validated HPLC-fluorescence detection method for endogenous farnesyl- (FPP) and geranylgeranylpyrophosphate (GGPP).Quantitative determination of vitamin D metabolites in plasma using UHPLC-MS/MS.High-resolution extracted ion chromatography, a new tool for metabolomics and lipidomics using a second-generation orbitrap mass spectrometer.Nanostructured solid substrates for efficient laser desorption/ionization mass spectrometry (LDI-MS) of low molecular weight compounds.Screening Dyrk1A inhibitors by MALDI-QqQ mass spectrometry: systematic comparison to established radiometric, luminescence, and LC-UV-MS assays.Novel galvanic nanostructures of Ag and Pd for efficient laser desorption/ionization of low molecular weight compounds.Account: characterization and identification of microcystins by mass spectrometry.Perspectives for Metabolomics in Human Nutrition: An Overview.Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients.From differentiating metabolites to biomarkers.Isotopic labeling of metabolites in drug discovery applications.Micro- and nanostructures and their application in gas chromatography.Vitamin D in chronic liver disease.Recent advances in sample preparation techniques to overcome difficulties encountered during quantitative analysis of small molecules from biofluids using LC-MS/MS.The hepatic phosphatidylcholine transporter ABCB4 as modulator of glucose homeostasis.How to prepare a manuscript fit-for-purpose for submission and avoid getting a 'desk-reject'.Metabolic engineering of the purine biosynthetic pathway in Corynebacterium glutamicum results in increased intracellular pool sizes of IMP and hypoxanthine.Comprehensive lipidomics analysis of bioactive lipids in complex regulatory networks.Fragmentation patterns of boron-dipyrromethene (BODIPY) dyes by electrospray ionization high-resolution tandem mass spectrometry.A rapid and sensitive assay for determining human brain levels of farnesyl-(FPP) and geranylgeranylpyrophosphate (GGPP) and transferase activities using UHPLC-MS/MS.Effect of acute inflammatory brain injury on accumulation of morphine and morphine 3- and 6-glucuronide in the human brain.Determination of hyperforin in mouse brain by high-performance liquid chromatography/tandem mass spectrometry.Gas-phase dissociation reactions of protonated saxitoxin and neosaxitoxin.Hyperforin modifies neuronal membrane properties in vivo.Intriguing differences in the gas-phase dissociation behavior of protonated and deprotonated gonyautoxin epimers.Periodicity in collision-induced and remote-bond activation of alkali metal ions attached to polyether ionophores.Plasma free fatty acid profiling in a fish oil human intervention study using ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry.Simultaneous quantification of acetaminophen and structurally related compounds in human serum and plasma.Structural study of spirolide marine toxins by mass spectrometry. Part I. Fragmentation pathways of 13-desmethyl spirolide C by collision-induced dissociation and infrared multiphoton dissociation mass spectrometry.
P50
Q30828849-9D990CF2-4075-4D56-8ED1-E28D3E293D8AQ33193907-E3901761-6AC8-4AE8-8EDC-8D3265338B1FQ33194349-96AF68C5-7CDC-4432-BB55-2DBB5EC973AEQ33217060-A6865ADE-C3FC-47B8-9DAE-4C0CE77D4065Q33240559-C347F9F0-ADF9-4239-84D1-CBE4B6EFF6CDQ33268463-4DE56F2A-CE6A-47AF-A9DE-0CBDF1140B5CQ33340769-A8E1B39F-5BC8-48DC-886B-B2B5D488B6D3Q33426174-688EEB28-534C-4BAA-BDC1-C7E398420EB4Q33459834-EAE78780-C9E8-4019-92F4-12F05B36E1EBQ33461868-D676BC48-DAA8-4EFC-AA2A-8E61E2C4E7B5Q33496221-D7BBA74C-FDDE-4C1A-83BB-5A38E7C2F7B2Q34071260-B30FC74D-0C9B-4504-AF60-02C66ED1F4FDQ34127403-1E6A9741-5E77-4B3F-9265-3981BFC4A741Q34269278-A5993F3A-3AE8-4682-B370-6F494BF2EBE3Q35019569-8A3ED8FF-B993-48E7-8425-3AA4DD817ADEQ35118036-DB5CDA7F-E520-4E65-9D6A-55018F22883EQ35128422-D53CCA9D-BAE0-405D-BAA8-4FE59DD423C5Q35177254-00891876-4A33-4852-B7C6-6CF5813378F8Q35296821-94C32B54-80C4-403B-BF94-6AE6BD9FCA23Q37187284-DAC577CB-D260-4BD9-9D79-E426D9D169C9Q37412408-D1EC372E-639F-4D1A-A894-1B58ECB058B7Q38004021-4D5EDCC8-DB32-4892-ADB6-DC9C9828DA11Q38017195-C72B03FC-EE46-4744-9067-16E33241095CQ38080943-28F0BD20-5AF1-43C1-B443-8A6E205AAC3CQ38196297-0F0FAF03-DC3D-4BD1-9745-BA393C0AE270Q38321700-CC459867-BCFB-4A47-8112-5FFFE401BB63Q38559142-C21DD9DB-7F30-4CEF-85EA-724512D67A82Q39531679-D17BCCB5-8F04-44E8-861C-6ACEDDEBD06EQ39657662-13098AF3-490F-4275-95E0-10D27CE9BD31Q40532743-CA632D3E-B0AE-4468-8887-868862FA086DQ42929621-6397A14D-4326-46DE-B42F-7B4E085F0E10Q43253132-30AEBB10-8BAC-4F8E-A630-7A48D81F6737Q44654650-448449EC-91DB-4927-9F3C-7DCEA766F951Q44816360-534B3425-6F8E-4BAD-AE6A-A92F458D889CQ45031936-AEE83C81-4743-40D7-9639-3D86540406B6Q45921077-E1DB56E8-2C8A-417A-946D-331FC304939AQ46388534-4FFB605D-19BD-44D2-96E0-0126CF1523BDQ46559480-E3C63DD3-E3E8-4D7F-8F0E-2E2C267AF7C4Q46912169-67FD9EFF-0286-43B0-B726-DC9BC29D62E6Q47359437-8515F39E-1133-4FBB-BDC8-34459E608E3E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dietrich A Volmer
@nl
Dietrich A Volmer
@sl
Dietrich A. Volmer
@en
Dietrich A. Volmer
@es
type
label
Dietrich A Volmer
@nl
Dietrich A Volmer
@sl
Dietrich A. Volmer
@en
Dietrich A. Volmer
@es
prefLabel
Dietrich A Volmer
@nl
Dietrich A Volmer
@sl
Dietrich A. Volmer
@en
Dietrich A. Volmer
@es
P106
P1153
7004183705
P21
P31
P496
0000-0003-2820-1480